• About us
• Contact

Advertisement

Person › Details

Douglas (Doug) Doerfler (MaxCyte Inc.)

Doerfler, Douglas (Doug) (MaxCyte 201006 CEO)

 

	Organisation	MaxCyte Inc.
	Group	MaxCyte (Group)
	Product	MaxCyte® STX™ Scalable Transfection System
	Product 2	Flow Electroporation® Technology

Record changed: 2018-11-11

Advertisement

More documents for Douglas (Doug) Doerfler

• [1] CRISPR Therapeutics AG. (11/9/18). "Press Release: CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology". Zug, Cambridge, MA & Gaithersburg, MD....
• [2] CRISPR Therapeutics AG. (3/14/17). "Press Release: CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte". Basel, Cambridge, MA & Gaithersburg, MD....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.